$ENZ climber gap Pr. $4.71 Fri, Jun 6, 2014, 8:
Post# of 44
Posted On: 06/06/2014 10:12:04 AM
$ENZ climber gap Pr. $4.71
Fri, Jun 6, 2014, 8:55AM EDT
Awarded U.S. Patent on More Efficient Vector
for Use in Gene Therapy news release
Website
10-Q 3/11/14
O/S shares 42,580,000
recent trades
Stockwatch
Consensus
Nasdaq
Enzo Biochem Awarded U.S. Patent on More Efficient Vector
for Use in Gene Therapy
6/6/2014 8:30:00 AM - Business Wire
Enzo Biochem Schedules Teleconference to Discuss
Third Quarter Results Tuesday, June 10, 2014 at 8:30 AM E.T.
6/3/2014 2:11:00 PM - Business Wire
Healthcare Stocks Little Changed; Enzo Biochem,
Innate Pharma Partnering on New Cancer Diagnosis Tools
5/30/2014 1:47:06 PM - MT Newswires
Sector Update: Healthcare
5/30/2014 1:30:53 PM - MT Newswires
Enzo Biochem Announces Appointment
of James M. O’Brien as Senior VP, Finance
5/30/2014 9:00:00 AM - Business Wire
% Buy Opinion (composite)
Fri, Jun 6, 2014, 8:55AM EDT
Awarded U.S. Patent on More Efficient Vector
for Use in Gene Therapy news release
Website
10-Q 3/11/14
O/S shares 42,580,000
recent trades
Stockwatch
Consensus
Nasdaq
Enzo Biochem Awarded U.S. Patent on More Efficient Vector
for Use in Gene Therapy
6/6/2014 8:30:00 AM - Business Wire
Enzo Biochem Schedules Teleconference to Discuss
Third Quarter Results Tuesday, June 10, 2014 at 8:30 AM E.T.
6/3/2014 2:11:00 PM - Business Wire
Healthcare Stocks Little Changed; Enzo Biochem,
Innate Pharma Partnering on New Cancer Diagnosis Tools
5/30/2014 1:47:06 PM - MT Newswires
Sector Update: Healthcare
5/30/2014 1:30:53 PM - MT Newswires
Enzo Biochem Announces Appointment
of James M. O’Brien as Senior VP, Finance
5/30/2014 9:00:00 AM - Business Wire
% Buy Opinion (composite)
(0)
(0)Enzo Biochem (ENZ) Stock Research Links
Scroll down for more posts ▼